Edition:
United States

Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

141.27USD
26 May 2017
Change (% chg)

$0.42 (+0.30%)
Prev Close
$140.85
Open
$140.97
Day's High
$141.59
Day's Low
$140.85
Volume
252,065
Avg. Vol
323,653
52-wk High
$141.59
52-wk Low
$106.48

Summary

Name Age Since Current Position

Kevin Lobo

51 2014 Chairman of the Board, President, Chief Executive Officer

Glenn Boehnlein

55 2016 Chief Financial Officer, Vice President

Lonny Carpenter

55 2009 Group President - Global Quality and Business Operations

David Floyd

56 2012 Group President - Orthopaedics

Graham Mclean

52 2017 President, Asia-Pacific

Timothy Scannell

52 2013 Group President - MedSurg and Neurotechnology

M. Fink

47 2016 Chief Human Resource Officer, Vice President

William Berry

51 2014 Principal Accounting Officer, Vice President, Corporate Controller

Bijoy Sagar

48 2014 Chief Information Officer, Vice President

Katherine Owen

46 2007 Vice President - Strategy and Investor Relations

Yin Becker

53 2016 Vice President - Communication and Public Affairs

Michael Hutchinson

46 2014 General Counsel

Howard Cox

74 1974 Independent Director

Srikant Datar

63 2009 Independent Director

Roch Doliveux

60 2010 Independent Director

Louise Francesconi

63 2006 Independent Director

Allan Golston

50 2011 Independent Director

Andrew Silvernail

46 2013 Independent Director

Ronda Stryker

62 1984 Independent Director

Biographies

Name Description

Kevin Lobo

Mr. Kevin A. Lobo is Chairman of the Board, President, Chief Executive Officer of the company. He was named Chairman of the Board in July 2014 and has served as President and Chief Executive Officer of the Company since 2012. He joined the Company as a Group President in April 2011. Prior thereto, he held several senior leadership roles over eight years with Johnson & Johnson, including serving as president of Ethicon Endo-Surgery. Mr. Lobo is also a director of Parker-Hannifin Corporation, a manufacturer of motion and control technologies and systems.

Glenn Boehnlein

Mr. Glenn S. Boehnlein is Chief Financial Officer, Vice President of Stryker Corporation. Mr. Glenn joined Stryker in 2003 as the Vice President of Finance and IT for Stryker’s Endoscopy division and has taken on roles of increasing responsibility, including his current role as Group CFO of MSNT, which he assumed in 2011. He has a strong and established track record and will continue to uphold the financial standards and practices that enable Stryker’s growth. Glenn’s career began with achieving a CPA degree and rising to Partner at Arthur Andersen, where he worked with large private and public companies, including private offerings and M&A transaction consulting. He then spent three years with Success TV as the company’s CFO prior to joining Stryker. Glenn received his Bachelors and Masters in Accounting from Mississippi State University.

Lonny Carpenter

Mr. Lonny J. Carpenter is Group President - Global Quality and Business Operations of the company. He was the Group President, Instruments and Medical since November 2008. He had previously been President, Stryker Medical since May 2008 and Vice President and General Manager, Stryker Medical since 2006. After joining the Company in 1989, Mr. Carpenter held various roles of increasing responsibility at Stryker Instruments before being promoted to Vice President, Global Operations, Stryker Instruments in 2004.

David Floyd

Mr. David K. Floyd is Group President - Orthopaedics of the company. He joins Stryker after 25 years in the medical technology and orthopaedics industry where he held a number of senior level leadership roles at DePuy, a division of Johnson and Johnson, Abbott Spine, AxioMed Spine, Centerpulse Orthopaedics and most recently as Chief Executive Officer for OrthoWorx.

Graham Mclean

Timothy Scannell

Mr. Timothy J. Scannell is Group President - MedSurg and Neurotechnology of the company. Mr. Scannell was Group President, Spine and Endoscopy since November 2008. He had previously been President, Stryker Spine since 2005 and Vice President and General Manager, Stryker Spine since 2003. After joining the Company in 1990, Mr. Scannell is leadership roles at Stryker Endoscopy before being promoted to Vice President and General Manager, Stryker Biotech in 2001.

M. Fink

William Berry

Bijoy Sagar

Katherine Owen

Ms. Katherine Ann Owen is Vice President - Strategy and Investor Relations of the company. Prior to joining the Company, She served as a medical technology analyst at Merrill Lynch. Prior to that she held a similar position at Cowen & Co./SG Cowen and had been a corporate lending analyst at State Street Bank.

Yin Becker

Michael Hutchinson

Howard Cox

Mr. Howard E. Cox, Jr., is Independent Director of Stryker Corp., since 1974. He is Special Limited Partner of Greylock and its affiliated venture capital partnerships since 1971. He is also a Director Secretary of Defense Business Board, a member of the Harvard Medical School Board of Fellows and a member of the Investment Committees of the Dana Farber Cancer Institute and the Boston Museum of Fine Arts. Mr. Cox has a broad and deep level of experience as a board member, having served on over 30 boards of directors, including many that were public companies and a number of which were in the healthcare industry.

Srikant Datar

Dr. Srikant M. Datar, Ph.D., is Independent Director of Stryker Corp. He is a Professor at the Graduate School of Business Administration of Harvard University since 1996. Faculty Chair of the Harvard Innovation Labs and Senior Associate Dean for University Affairs. From 1989 to 1996, he was Edmund W. Littlefield Professor at the Graduate School of Business, Stanford University. Dr. Datar is also a director of Novartis AG, a multinational pharmaceutical and consumer health products company, ICF International, Inc., a management, technology and policy consulting firm, and T-Mobile US, Inc., a provider of wireless voice, messaging and data services.

Roch Doliveux

Dr. Roch Doliveux, DVM, is Independent Director of Stryker Corp., since June 21, 2010. He is a Former Chief Executive Officer and Chairman of the Executive Committee of UCB S.A., a global biopharmaceutical company, from 2005 through 2014. Prior thereto, he was Chief Executive Officer of Pierre Fabre Pharmaceuticals and President of Schering-Plough International, a subsidiary of Schering-Plough Corporation, now Merck and Co. He is Chairman of the GLG Healthcare Institute, a community of senior executives for experience sharing and learning and Vice Chairman of the Board of the Vlerick Business School, a top-100 business school in the world based in Belgium.

Louise Francesconi

Ms. Louise L. Francesconi is Independent Director of Stryker Corp., since July 26, 2006. She is Former Vice President of Raytheon Company and former President of Raytheon Missile Systems, which she led from 1996 to July 2008. She is Chairman of the Tucson Medical Center Healthcare Board of Trustees and a director of UNS Energy Corporation, a utility that delivers natural gas and electric service.

Allan Golston

Mr. Allan C. Golston is Independent Director of Stryker Corp., since January 1, 2011. He served as President, United States Program for the Bill & Melinda Gates Foundation since 2006, and Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. Mr. Golston is also a director of Harley-Davidson, Inc., a manufacturer of motorcycles and accessories. Mr. Golston has extensive experience in auditing, finance and the healthcare industry. He is a Certified Public Accountant and has held positions as a finance executive with Swedish Health Services (Seattle, WA) and the University of Colorado Hospital.

Andrew Silvernail

Mr. Andrew K. Silvernail is Independent Director of the company. He is Chairman, President and Chief Executive Officer of IDEX Corporation, Chairman since 2012 and President and Chief Executive Officer since 2011, and Vice President, Group Executive from January 2009 to August 2011. Mr. Silvernail is also a trustee for the Manufacturers Alliance for Productivity and Innovation (MAPI).

Ronda Stryker

Ms. Ronda E. Stryker is Independent Director of Stryker Corp., since 1984. She is also Vice Chair and a director of Greenleaf Trust, a Michigan chartered bank, Vice Chair of Spelman College, a trustee of Kalamazoo College and member of the Harvard Medical School Board of Fellows.